Holtsberg FW - Search Results

1

Presence in human eosinophils of a lysophospholipase similar to that found in the pancreas.

Holtsberg FW, Ozgur LE, Garsetti DE, Myers J, Egan RW, Clark MA. Holtsberg FW, et al. Biochem J. 1995 Jul 1;309 ( Pt 1)(Pt 1):141-4. doi: 10.1042/bj3090141. Biochem J. 1995. PMID: 7619049 Free PMC article.

2

Butyric acid-induced differentiation of HL-60 cells increases the expression of a single lysophospholipase.

Garsetti D, Holtsberg F, Steiner MR, Egan RW, Clark MA. Garsetti D, et al. Biochem J. 1992 Dec 15;288 ( Pt 3)(Pt 3):831-7. doi: 10.1042/bj2880831. Biochem J. 1992. PMID: 1471998 Free PMC article.

3

Comparison of six mammalian lysophospholipases.

Garsetti DE, Steiner MR, Holtsberg F, Ozgür LE, Egan RW, Clark MA. Garsetti DE, et al. J Lipid Mediat. 1993 Mar-Apr;6(1-3):223-32. J Lipid Mediat. 1993. PMID: 8357983

4

Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxin.

Thomas JB, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA. Thomas JB, et al. Among authors: holtsberg fw. Biochem J. 2002 May 1;363(Pt 3):581-7. doi: 10.1042/0264-6021:3630581. Biochem J. 2002. PMID: 11964159 Free PMC article.

5

Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.

Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA. Ensor CM, et al. Among authors: holtsberg fw. Cancer Res. 2002 Oct 1;62(19):5443-50. Cancer Res. 2002. PMID: 12359751

6

Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies.

Bomalaski JS, Holtsberg FW, Ensor CM, Clark MA. Bomalaski JS, et al. Among authors: holtsberg fw. J Rheumatol. 2002 Sep;29(9):1942-9. J Rheumatol. 2002. PMID: 12233890

7

Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties.

Holtsberg FW, Ensor CM, Steiner MR, Bomalaski JS, Clark MA. Holtsberg FW, et al. J Control Release. 2002 Apr 23;80(1-3):259-71. doi: 10.1016/s0168-3659(02)00042-1. J Control Release. 2002. PMID: 11943403

8

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation.

Dillon BJ, Prieto VG, Curley SA, Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA. Dillon BJ, et al. Among authors: holtsberg fw. Cancer. 2004 Feb 15;100(4):826-33. doi: 10.1002/cncr.20057. Cancer. 2004. PMID: 14770441 Free article.

9

Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production.

Dillon BJ, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA. Dillon BJ, et al. Among authors: holtsberg fw. Med Sci Monit. 2002 Jul;8(7):BR248-53. Med Sci Monit. 2002. PMID: 12118186

10

Regression of hepatocellular cancer in a patient treated with arginine deiminase.

Curley SA, Bomalaski JS, Ensor CM, Holtsberg FW, Clark MA. Curley SA, et al. Among authors: holtsberg fw. Hepatogastroenterology. 2003 Sep-Oct;50(53):1214-6. Hepatogastroenterology. 2003. PMID: 14571701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters